E3 PreliminaryPreliminaryPEM unclearObservationalPeer-reviewedReviewed
HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndrome.
Rodrigues, Lucas S, da Silva Nali, Luiz H, Leal, Cibele O D et al. · Auto- immunity highlights · 2019 · DOI
Quick Summary
This study looked at whether certain viral fragments called HERV-K and HERV-W were more active in the blood of ME/CFS patients. Researchers found that HERV-K was elevated in people with moderate ME/CFS but not in those with severe disease, while HERV-W showed no difference. These findings suggest that viral elements may play a role in ME/CFS, though much more research is needed to understand what this means.
Why It Matters
This study provides preliminary evidence that endogenous retroviruses may be involved in ME/CFS biology, potentially identifying new biomarkers or disease mechanisms. If HERV-K activity is confirmed in future research, it could lead to better diagnostic tests and targeted treatments for ME/CFS patients.
Observed Findings
- HERV-K was overexpressed in blood samples from moderately affected ME/CFS patients
- HERV-W showed no statistically significant difference between patient groups
- The differential expression of HERV-K was specific to the moderate disease group, not the severely affected group
- This represents the first report of HERV-K differential expression patterns in ME/CFS
Inferred Conclusions
- Endogenous retroviruses, particularly HERV-K, may play a role in ME/CFS pathogenesis and warrant further investigation as potential biomarkers
- The differential expression pattern across disease severity suggests a complex relationship between viral activation and clinical presentation
- HERV-K activity deserves attention in future mechanistic and longitudinal studies of ME/CFS
Remaining Questions
- Why is HERV-K elevated in moderate disease but not severe disease? Does this suggest a different biological process at different disease stages?
- What is the functional significance of elevated HERV-K expression—does it contribute to symptoms, or is it merely a marker of immune dysregulation?
- Would HERV-K expression change over time within individual patients, or is this a stable characteristic?
What This Study Does Not Prove
This study does not prove that HERV-K causes ME/CFS or explain why it is elevated in moderate disease but not severe disease. It also does not establish a direct functional relationship between HERV expression and disease symptoms, and findings from a single cross-sectional study require replication before clinical application.
Tags
Symptom:Fatigue
Biomarker:Gene ExpressionBlood Biomarker
Phenotype:Severe
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.1186/s13317-019-0122-8
- PMID
- 32257068
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.